Reduction in gastrointestinal bleeding by development and implementation of a protocol for stress ulcer prophylaxis: a before-after study
- PMID: 26819744
- PMCID: PMC4729099
- DOI: 10.1186/s40780-015-0034-3
Reduction in gastrointestinal bleeding by development and implementation of a protocol for stress ulcer prophylaxis: a before-after study
Abstract
Background: The implementation of a protocol has been associated with improvements in the processes of care in clinical settings. Although stress ulcer prophylaxis is recommended for critically ill patients at high risk, there is currently no consensus on its use. Therefore, we herein developed a protocol for stress ulcer prophylaxis, and evaluated therapeutic outcomes in a before-after study.
Methods: The protocol was developed by considering the effectiveness, disadvantages (including adverse events) and cost of each agent based on previous findings. Patients who were admitted to the 8-bed emergency intensive care unit (ICU) of our hospital for more than 24 h during the year before and after implementation of the study were eligible. Each investigation item was evaluated retrospectively.
Results: There were 211 and 238 study patients before and after implementation of the protocol, respectively. The baseline characteristics of patients on/during ICU admission were similar in the two groups. The proportion of medicated patients was 79.6 % before and 84.5 % after protocol implementation. Before implementation of the protocol, 4.3 % of patients developed clinically important gastrointestinal bleeding, and this incidence decreased significantly to 0.8 % after its implementation (P = 0.019). The frequency at which medication was discontinued due to adverse events was slightly lower after implementation of the protocol. No significant differences were observed in the costs of stress ulcer prophylactic agents or mortality in the ICU.
Conclusions: The results of the present study indicated that the development and implementation of a protocol for stress ulcer prophylaxis, for which there are currently no criteria, improved a main outcome, clinically important gastrointestinal bleeding.
Keywords: Clinically important bleeding; Intensive care unit; Protocol; Stress ulcer prophylaxis.
Figures

Similar articles
-
Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.Trials. 2016 Apr 19;17(1):205. doi: 10.1186/s13063-016-1331-3. Trials. 2016. PMID: 27093939 Free PMC article. Clinical Trial.
-
Impact of the stress ulcer prophylactic protocol on reducing the unnecessary administration of stress ulcer medications and gastrointestinal bleeding: a single-center, retrospective pre-post study.J Intensive Care. 2020 Jan 16;8:10. doi: 10.1186/s40560-020-0427-8. eCollection 2020. J Intensive Care. 2020. PMID: 31988751 Free PMC article.
-
Effects of stress ulcer prophylaxis in adult ICU patients receiving renal replacement therapy (Sup-Icu RENal, SIREN): Study protocol for a pre-planned observational study.Trials. 2018 Jan 10;19(1):26. doi: 10.1186/s13063-017-2408-3. Trials. 2018. PMID: 29321041 Free PMC article.
-
Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.Intensive Care Med. 2019 Feb;45(2):143-158. doi: 10.1007/s00134-019-05526-z. Epub 2019 Jan 24. Intensive Care Med. 2019. PMID: 30680444
-
Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.Pharmacotherapy. 2019 Mar;39(3):408-420. doi: 10.1002/phar.2172. Epub 2018 Sep 6. Pharmacotherapy. 2019. PMID: 30101529
Cited by
-
Impact of physician-pharmacist collaborative protocol-based pharmacotherapy management for HIV outpatients: a retrospective cohort study.J Pharm Health Care Sci. 2020 May 1;6:9. doi: 10.1186/s40780-020-00165-9. eCollection 2020. J Pharm Health Care Sci. 2020. PMID: 32377369 Free PMC article.
References
-
- ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;56:347–379. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources